Seasoned nurses know the ins and outs of the job, therefore they can be the best resource for those who are just beginning their career.
Matthew Galsky, MD, medical oncologist, Icahn School of Medicine at Mount Sinai, discusses treating different subsets of bladder cancer.
Gary H. Lyman, MD, MPH, Fred Hutchinson Cancer Research Center, discusses the immediate and long-term effects of febrile neutropenia.
Fadlo R. Khuri, MD, FACP, professor, chair, hematology/medical oncology, Emory University School of Medicine, deputy director, Winship Cancer Institute, discusses what oncology nurses should know about survivorship today.
When patients are experiencing cancer-related fatigue, oncology nurses might want to consider referring them to cognitive behavior therapy (CBT).
How Kathleen Shannon Dorcy, PhD, RN, FAAN, became a leading voice in oncology nursing.
The journey toward vicarious resilience is not only possible but essential—for ourselves, our patients, and it is the very essence of health care.
Jennifer Wenzel, PhD, RN, CCM, FAAN, discusses why representation in clinical trials is not successful as an afterthought.
Maria Cabanillas, MD, explains that for people who are newly diagnosed with thyroid cancer, it is imperative that they know all the details about their cancer before heading into surgery.
Research has demonstrated that integrating palliative care early for patients with advanced cancer improves outcomes such as quality of life, mood, patient satisfaction, prognostic understanding, health service use, and survival.
Carol Cannon, RN, BSN, OCN, Oncology Program Specialist, Nurse Oncology Education Program, Austin, Texas, discusses the ONS Get Up, Get Moving Campaign.
Women living in certain areas of the United States may face health risks due to their limited access to specialized gynecologic cancer care.
Balancing quality-of-life concerns with treatment goals is complicated for young patients with hormone-sensitive breast cancers.
In the current digital age, where all-too-personal information flows from Facebook and Twitter, it seems that the health information available through the process of genetic testing would be an idea welcomed by most of the public.
For patients with cancer, their journey does not end after treatment is over.
Deirdre Kiely, MS, MPA, RN, ANP, nurse practitioner, Perlmutter Cancer Center at NYU Langone Medical Center, discusses some of the challenges of getting breast cancer patients to exercise routinely.
When patients with MCL develop resistance to chemotherapy and targeted therapies, experts believe CAR T-cell therapy can step in.
Debu Tripathy discuss how to encouragecompliance and adherence for patients with breast cancer who are receiving hormone therapy.
Carol Tringali on Closing the Gaps in Psychosocial Care
There are some adverse events that are common to all PARP inhibitors, and others that are specific to each drug.
Melanie A. Nix, co-founder of the Breast Cancer Comfort Site, comments on the importance of social media in advocacy.
Mary McCabe, director, Cancer Survivorship Initiative, Memorial Sloan Kettering Cancer Center, discusses the evolution of survivorship care.
About a third of breast cancer survivors are still living with fatigue and reduced exercise capacity after treatment ends.
Survivors of childhood cancer who are overweight or obese as adults are at an increased risk of developing an obesity-related cancer.
Robert Andtbacka, MD, associate professor, Division of Surgical Oncology Department of Surgery, University of Utah School of Medicine, discusses past, present, and future trials for T-VEC.
Mark E. Robson, MD, Clinical Director of the Clinical Genetics Services at Memorial Sloan Kettering Cancer Center, discusses when it is appropriate to go for genetic testing to determine cancer risk.
Kathleen M. Madden discusses the management of adverse events (AEs) with BRAF and MEK inhibitors for the treatment of patients with melanoma.
Gregory T. Armstrong, MD, MSCE, pediatric oncologist, St. Jude Children's Research Hospital, discusses a trial of 34,000 childhood cancer survivors.
Research has shown that pain and anxiety are related to port access, so a need exists to capture patients’ feelings and emotions related to living with a port, as well as effective nursing interventions aimed at addressing those patient experiences.